91
Participants
Start Date
November 30, 2007
Primary Completion Date
February 28, 2010
Study Completion Date
May 31, 2010
eptifibatide
Enrolled patients will be randomized in the catheterization laboratory, after the decision to perform PCI by means of planned implantation of DES \>33 mm in length in the same coronary vessel, to IV placebo or IV eptifibatide (double bolus \[180 microg/kg\] followed by infusion \[2 microg/kg per minute\] for 18 to 24 hours after the procedure
placebo
Enrolled patients will be randomized in the catheterization laboratory, after the decision to perform PCI by means of planned implantation of DES \>33 mm in length in the same coronary vessel, to IV placebo or IV eptifibatide (double bolus \[180 microg/kg\] followed by infusion \[2 microg/kg per minute\] for 18 to 24 hours after the procedure
Mediolanum Cardio Research, Milan
Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS
OTHER